
Coaching / 1:1
A deep-dive pitch deck review with a written report and customized investor shortlist - for biotech founders who want honest, investor-calibrated feedback before they start pitching.
Most pitch feedback is generic. This isn't.
Before we get on a call, you send me your deck. I review it the way a biotech investor would, evaluating your narrative, science translation, market framing, and flag any gaps that can quietly kill your fundraise.
I come prepared with recommendations biased for action.
Here's how it works:
Before the call - You email me your current deck. I do a full review, slide by slide, and identify your key positioning gaps and highest-leverage fixes.
On the call (60 minutes) - We work through the feedback together. You'll understand exactly why certain slides aren't landing, what investors are actually looking for at your stage, and how to sharpen your story.
After the call - You receive a written report with slide-by-slide notes, an executive strategic summary, and a customized investor shortlist - a curated list of investors who are a strong fit for your modality, stage, and thesis, so you're not starting your search from scratch.
You leave knowing exactly what to fix, how to say it, and who to pitch.
What's included:
Pre-call in-depth deck review
60-minute strategy session
Slide-by-slide written feedback
Executive strategic summary
Customized investor shortlist (tailored to your stage, modality & thesis)
Priority fixes identified
Scheduling: Please schedule your Strategy Session 3-5 business days in advance to ensure proper time for review of your materials.
About Vadim
I've spent over a decade in pharma Business Development and Corporate Strategy, including roles at Pfizer, BeiGene, and as Chief Business & Operating Officer at a pre-clinical biotech. I now advise early-stage founders through Bench2Bio and publish Bio Founder GPS, a weekly newsletter read by 1,000+ biotech founders.
I've reviewed hundreds of pitch decks and sat on both sides of the table - as a startup operator, investor, pharma BD partner, and mentor at IndieBio and American Cancer Society BrightEdge.
My goal is for you to walk out of this audit with a sharper story and a shorter path to the investors who matter - so you can build the business that your science deserves.
What founders say
“He is very thorough and it is demonstrated in the work output. Our deck was a compromise: great content, less than great format. He recognized it, understood why I made those decisions, but explained that we need to be firing on all cylinders. It changed my perspective.”
Gary Kellstrom, Jr., CEO and Founder
“He helped us shape a clearer, more compelling narrative while focusing on the key concepts that matter most to investors. We would warmly recommend him to any founder embarking on the fundraising journey.”
Liat and Milit, Co-founders
“Vadim has a great way of cutting through the clutter and focusing on what matters most. Love his organized and methodical approach!”
Cheryl Kerr, CBO
My Guarantee
If you don't walk away with actionable clarity on your deck and a clear sense of who to pitch next, I'll refund your investment in full - no questions asked.